Three committees share the responsibilities of the Institutional Review Board.
An Institutional Review Board (IRB) is a committee, including volunteers from Ohio State and its surrounding community, whose primary responsibility is to protect the rights and welfare of human research subjects. The authority conveyed to the IRBs includes decisions to approve, disapprove, require modifications, monitor, suspend and terminate research projects involving human subjects.
There are three internal IRBs at Ohio State that review, approve, and conduct periodic reviews of research involving human subjects (including data and biological materials obtained from human subjects) to ensure risks have been minimized and the potential for benefit has been maximized for human subjects participating in the research.
Member Rosters and Meeting Dates
Behavioral and Social Sciences IRB
Does not review investigator-initiated (funded or unfunded) research that:
- involve medical procedures, drugs, or devices, originating from a variety of disciplines including the arts, humanities, business, communication, education, music, nursing, political science, psychology, sociology, and social work
- FDA-regulated research
Member Rosters
Meeting Dates
Meetings will be held virtually until further notice from 11 a.m. – 1 p.m.
- January 17, 2025
- February 21, 2025
- March 21, 2025
- April 18, 2025
- May 16, 2025
- June 20, 2025
Biomedical Sciences IRB
- reviews investigator-initiated (funded or unfunded) biomedical research, excluding cancer research
- does not review industry-initiated, industry-sponsored clinical trials
Member Rosters
Meeting Dates
Meetings will be held virtually until further notice at 2 p.m.
- January 13th, 2025
- January 27th, 2025
- February 10th, 2025
- February 24th, 2025
- March 10th, 2025
- March 24th, 2025
- April 14th, 2025
- April 28th, 2025
- May 12th, 2025
- May 19th, 2025
- June 9th, 2025
- June 23rd, 2025
Cancer IRB
- reviews investigator-initiated (funded or unfunded) research involving cancer surveillance, etiology, diagnosis, early detection, prevention, treatment, symptom control and survivorship studies, including quantitative, observational and interventional study designs
- does not review industry-initiated, industry-sponsored cancer clinical trials
Member Rosters
Meeting Dates
Meetings will be held virtually until further notice at 2 p.m.
- January 6th, 2025
- January 27th, 2025
- February 3rd, 2025
- February 17th, 2025
- March 3rd, 2025
- March 17th, 2025
- April 7th, 2025
- April 21st, 2025
- May 5th, 2025
- May 19th, 2025
- June 2nd, 2025
- June 16th, 2025